Topic Highlight
Copyright ©The Author(s) 2016.
World J Gastroenterol. Jul 7, 2016; 22(25): 5642-5654
Published online Jul 7, 2016. doi: 10.3748/wjg.v22.i25.5642
Table 2 Assessment of disease activity with advanced endoscopic imaging in the context of clinical trials
Ref.TechniqueNo. of patientsFindings
Kiesslich et al[84], 2003CE165Agreement with histology: 84.5% (72 of 84) vs 60% (49 of 81)
Kudo et al[85], 2009NBI30Obscure mucosal vascular pattern is associated with inflammatory cell infiltrates (26% vs 0%), goblet cell depletion (32% vs 5%), and basal plasmacytosis (2% vs 21%)
Danese et al[87], 2010NBI14Positive appearance on NBI correlated with increase in angiogenesis or vessel density
Neumann et al[88], 2013Virtual CE (i-Scan)78Inflammatory extent and activity accordance with the histological results: 48.71% and 53.85% (white-light) and 92.31% and 89.74% (i-Scan)
Watanabe et al[89], 2008CLE17Distinct alterations in active and non-active UC patients compared to histology
Li et al[90], 2010CLE73Crypt architecture and fluorescein leakage with CLE correlate with histological results
Neumann et al[92], 2012CLE54CDEAS consisting of six parameters: crypt number, crypt distortion, micro erosions, cellular infiltrate, vascularity, and number of goblet cells
Strong correlation of CDEAS and CRP